The Nassau Guardian

Topical fluoride: One of the best ways to prevent tooth decay

Tooth decay remains one of the most common chronic diseases affecting children and adults. Fortunately, it is also one of the ...

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
MPR

Zoryve Cream 0.05% Under FDA Review for Infant Atopic Dermatitis

In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.
Forbes

How To Check Your Discover Application Status

Cole Schenewerk’s passion for credit card points and miles has led him around the globe. Following a career in corporate finance, he now helps others maximize the rewards they earn from their spending ...